Pulmofib 200 mg Tablet Substitute

Substitutes of Pulmofib 200 mg Tablet meet the same safety and efficacy standards as Pulmofib 200 mg Tablet , but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.

Yes. Substitutes of Pulmofib 200 mg Tablet may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.

Yes, it’s generally safe to switch between multiple substitutes of Pulmofib 200 mg Tablet if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.

Yes, many people safely use substitutes of Pulmofib 200 mg Tablet for long-term treatment. Just ensure it’s done under medical supervision.

If your symptoms stay under control or lab results remain stable, the substitute for Pulmofib 200 mg Tablet is likely working well. Regular follow-ups with your doctor are important.

Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Pulmofib 200 mg Tablet to its substitute. Always consult your doctor before switching.

Pulmofib 200 mg Tablet is used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF is an irreversible disease that is marked by a progressive decline in lung function.

Pulmofib 200 mg Tablet helps in reducing the scarring and swelling in the lungs by decreasing the release/activity of naturally occurring growth factors in the body, thereby helps you breathe better.

Pulmofib 200 mg Tablet might make you photosensitive (sensitivity to sunlight). Avoid exposure to sunlight and sunlamps. Wear SPF 50+ sunscreen and protective clothing to reduce exposure to sunlight. Talk to your doctor if you are taking any medicines known to cause photosensitivity. If you notice any symptoms of photosensitivity, consult a doctor.

Do not discontinue Pulmofib 200 mg Tablet without consulting your doctor. To treat your condition effectually, continue taking Pulmofib 200 mg Tablet for as long as prescribed. Do not be reluctant to speak with your doctor if you experience any difficulty while taking Pulmofib 200 mg Tablet .

Diarrhoea might be a side-effect of Pulmofib 200 mg Tablet . Drink lots of fluids and eat non-spicy food if you experience diarrhoea. If you find blood in stools (tarry stools) or if you have severe diarrhoea, consult your doctor. Do not take anti-diarrheal medicine on your own.

No, avoid smoking prior to the start of the treatment and while taking Pulmofib 200 mg Tablet as smoking might alter the effectiveness of Pulmofib 200 mg Tablet .

Weight loss could occur due to loss of appetite. Maintain proper weight by eating healthy food. Your doctor might monitor your weight whilst taking Pulmofib 200 mg Tablet . Consult your doctor if you notice severe weight loss.

Pulmofib 200 mg Tablet is not recommended for children below 18 years as the safety and effectiveness have yet to be established.

Taking Pulmofib 200 mg Tablet on an empty stomach may cause stomach discomfort. So, take Pulmofib 200 mg Tablet with food. Swallow Pulmofib 200 mg Tablet as a whole with a glass of water; do not chew or crush it.

While taking Pulmofib 200 mg Tablet , your doctor will monitor you regularly for potential side effects. This includes checking your liver and kidney function, blood cell count, weight, and skin for any reactions. They will also perform eye exams and monitor your lung function. Regular check-ups are crucial to ensure safe treatment. Be sure to follow your doctor's instructions and attend all scheduled appointments.

Continuing treatment with Pulmofib 200 mg Tablet is crucial because it helps slow down the progression of idiopathic pulmonary fibrosis (IPF), reduces the risk of lung function decline, and manages symptoms like cough and shortness of breath. This helps improve your quality of life and keeps you active. Stopping treatment may lead to disease progression, so it's essential to stick with your treatment plan and consult your doctor for personalized advice.

Common side effects of Pulmofib 200 mg Tablet may include nausea, tiredness, diarrhoea, indigestion, loss of appetite, headache, and photosensitivity. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

No, Pulmofib 200 mg Tablet is not a steroid. It is an antifibrotic medication, which means it helps to reduce scarring (fibrosis) in the lungs. It reduces inflammation and slows the progression of idiopathic pulmonary fibrosis (IPF), a chronic lung disease. While steroids can be used to reduce inflammation, Pirfenidone is a specific medication designed to target fibrosis in the lungs and has a different mechanism of action.

Pulmofib 200 mg Tablet is right for you if you have idiopathic pulmonary fibrosis (IPF) and your doctor has prescribed it to slow down lung scarring and progression.

Do not discontinue Pulmofib 200 mg Tablet without consulting your doctor, even if your condition appears to be under control. Stopping the medication abruptly may lead to a resurgence of symptoms and a loss of progress made. Continue taking the medication as prescribed and only discontinue use under the guidance of your healthcare provider. Regular monitoring and adjustments to your treatment plan will help ensure the best possible management of your condition.

While taking Pulmofib 200 mg Tablet , be sure to avoid excessive sun exposure and use sunscreen to protect your skin. Quit smoking to ensure the medication works effectively and to improve your overall health. Also, refrain from taking other medications without consulting your doctor, as they may interact with Pulmofib 200 mg Tablet . Additionally, limit your consumption of grapefruit and grapefruit juice to minimize potential side effects. By following these guidelines, you can safely manage your treatment and optimize your health outcomes.

The survival rate of pulmonary fibrosis varies depending on several factors, including the patient's age, health, lifestyle, and the severity of the disease at diagnosis. According to the European Respiratory Society, the median overall survival time of patients with idiopathic pulmonary fibrosis (IPF) is 4.5 years. However, survival rates can vary significantly, with some patients living up to 10 years or more after diagnosis.